Home » Stocks » Eyenovia

Eyenovia, Inc. (EYEN)

Stock Price: $3.62 USD 0.15 (4.32%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $3.75 +0.13 (3.59%) Oct 27, 4:41 PM

Stock Price Chart

Key Info

Market Cap 86.41M
Revenue (ttm) n/a
Net Income (ttm) -20.36M
Shares Out 23.87M
EPS (ttm) -1.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $3.62
Previous Close $3.47
Change ($) 0.15
Change (%) 4.32%
Day's Open 3.46
Day's Range 3.42 - 3.70
Day's Volume 168,971
52-Week Range 1.11 - 6.92

More Stats

Market Cap 86.41M
Enterprise Value 76.95M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 23.87M
Float 14.16M
EPS (basic) -1.13
EPS (diluted) -1.15
FCF / Share -0.91
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 68,090
Short Ratio 0.42
Short % of Float 0.48%
Beta 2.29
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 10.42
Revenue n/a
Operating Income -20.47M
Net Income -20.36M
Free Cash Flow -18.05M
Net Cash 9.46M
Net Cash / Share 0.40
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -119.21%
ROE -255.47%
ROIC 1,384.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(231.49% upside)
Current: $3.62
Target: 12.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-21.31-17.26-5.13-3.53-4.27
Net Income-21.16-17.25-5.13-3.53-4.27
Shares Outstanding14.359.482.342.272.27
Earnings Per Share-1.47-1.82-2.19-1.56-1.88
Operating Cash Flow-18.92-13.11-4.73-3.20-3.83
Capital Expenditures-0.17-0.03-0.01-0.04-
Free Cash Flow-19.09-13.14-4.74-3.25-3.83
Cash & Equivalents14.1519.735.253.392.49
Net Cash / Debt14.1519.735.253.392.49
Book Value11.7416.885.093.012.40
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Eyenovia, Inc.
Country United States
Employees 27
CEO Sean Ianchulev

Stock Information

Ticker Symbol EYEN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: EYEN
IPO Date January 25, 2018


Eyenovia, a clinical stage ophthalmic biopharmaceutical company, engages in developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, branded the Optejet. It focuses on achieving clinical microdosing of next-generation formulations of ophthalmic pharmaceutical agents using its ocular delivery system, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. The company, through its proprietary delivery technology, is developing smart ophthalmic therapies while targeting new indications for which there are currently no drug therapies approved by the U.S. Food and Drug Administration. Eyenovia, Inc. focuses on advancing its MicroLine program for the improvement in near vision in patients with presbyopia in Phase III development. Its other product candidates include MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma, open angle glaucoma, and ocular hypertension; MicroStat, which has completed Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of red eye and itch relief lubrication; and MicroPine for the treatment of progressive myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.